Abstract Coronavirus disease 2019 (COVID-19) is a global pandemic caused by SARS-CoV-
2 infection and is associated with both acute and chronic disorders affecting the nervous …

Background and purpose Although COVID‐19 predominantly affects the respiratory system,
recent studies have reported the occurrence of neurological disorders such as stroke in …

Objective We sought to review the literature on cerebrospinal fluid (CSF) testing in patients
with COVID-19 for evidence of viral neuroinvasion by SARS-CoV-2. Methods We performed …

Immune-related manifestations are increasingly recognized conditions in patients with
COVID-19, with around 3,000 cases reported worldwide comprising more than 70 different …

Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) predominantly
infects the respiratory system, several investigations have shown the involvement of the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the aetiologic agent of the
coronavirus disease 2019 (COVID-19), is now rapidly disseminating throughout the world …

Background Recent findings indicated that severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2)-related neurological manifestations involve cytokine release syndrome along …

As of May 2022, there have been more than 527 million infections with severe acute
respiratory disease coronavirus type 2 (SARS-CoV-2) and over 6.2 million deaths from …

Objective Many neurological manifestations are associated with COVID‐19, including a
distinct form of encephalopathy related to cytokine storm, the acute systemic inflammatory …

Growing evidence demonstrates the association of encephalitis, meningoencephalitis or
encephalomyelitis, with SARS-CoV-2 infection. This study aims to determine the profile and …